Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 26th October 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dog owners sought for autoimmune disease research
The study will collect information about dogs that have been recently diagnosed with an autoimmune disease.
Study will be the largest of its kind ever conducted in veterinary medicine.

Owners of dogs with autoimmune diseases are being called upon to participate in a vital piece of new research being undertaken by the RVC.

The research will be one of the largest studies of autoimmune diseases ever conducted and aims to collate data and insight into the diagnosis, treatment response and outcomes of dogs with autoimmune conditions.

Results will be distributed among local veterinary practices and specialist hospitals to help owners and vets make informed decisions when their animals are diagnosed.

Dr Barbara Glanemann, lead researcher and senior lecturer in Small Animal Medicine at the RVC, said: “This study will be the first time that the treatment and progress of dogs with autoimmune diseases has been investigated outside universities, providing an essential perspective on the challenges faced by affected dogs and their owners in wider veterinary practice."

The study, named the ImmunoRegistry, has been launched to address the current shortage of information about autoimmune diseases. It will garner information about dogs that have been recently diagnosed with an autoimmune disease, following them for a year in real-time to learn how they respond to treatment.

In total, the team aims to collect information from 400 dogs, making it the largest planned study of autoimmune diseases ever conducted in veterinary medicine globally and providing a crucial resource for future research.

James Swann, a postdoctoral fellow at Columbia University, New York, said: "There is an urgent need to optimise the treatment of dogs with autoimmune diseases, and this study represents an important first step in gathering vital information to make clinical recommendations and guide future research projects.”

For more information about the study, along with the criteria for enrolment, visit rvc.onlinesurveys.ac.uk/immunoregistry

 

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.